In vivo, CD4+ T cells co-expressing CAR T cells unique to B7H6 mouse tumors and overexpressing T-bet promoted anti-tumor responses and lengthened the survival of RMA-B7H6 lymphoma-bearing mice.69 Here, NCR3LG1 is linked to neoplasm.